A Study to Compare How Much Solifenacin Succinate and Mirabegron Reach the Blood When Administered Together as Fixed-dose Combination Tablets and With Single Individual Tablets of the Same Medications at Three Dose Levels

NCT02010944 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Phase 1
Bioavailability
Healthy Subjects

Interventions

DRUG: solifenacin succinate
DRUG: mirabegron
DRUG: mirabegron/solifenacin succinate

Sponsor

Astellas Pharma Europe B.V.